Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Healthstream (HSTM) Return on Sales (2016 - 2026)

Healthstream has reported Return on Sales over the past 16 years, most recently at 0.0% for Q4 2025.

  • Quarterly Return on Sales changed 0.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Sales was 0.0% for Q4 2025 at Healthstream, up from 0.0% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.0% in Q4 2025 and troughed at 0.0% in Q4 2021.
  • The 5-year median for Return on Sales is 0.0% (2022), against an average of 0.0%.
  • The largest YoY upside for Return on Sales was 0bps in 2021 against a maximum downside of 0bps in 2021.
  • A 5-year view of Return on Sales shows it stood at 0.0% in 2021, then soared by 1063bps to 0.0% in 2022, then fell by -7bps to 0.0% in 2023, then rose by 22bps to 0.0% in 2024, then skyrocketed by 41bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Return on Sales are 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).